{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:14:07Z","timestamp":1788869647374,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00404-016-4261-0","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T09:47:19Z","timestamp":1481104039000},"page":"529-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?"],"prefix":"10.1007","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-4196","authenticated-orcid":false,"given":"Magdalini","family":"Patseadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Michala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,7]]},"reference":[{"key":"4261_CR1","unstructured":"Mirena Product Monograph (2014) Bayer Pharma AG, Berlin. Available at: http:\/\/www.mirena.com\/html\/pdf\/MirenaProductMonograph.pdf . Accessed May 24, 2015"},{"key":"4261_CR2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0010-7824(91)90135-3","volume":"43","author":"B Jonsson","year":"1991","unstructured":"Jonsson B, Landgren B-M, Eneroth P (1991) Effects of various IUDs on the composition of cervical mucus. Contraception 43:447\u2013458","journal-title":"Contraception"},{"issue":"Suppl. 3","key":"4261_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/humrep\/15.suppl_3.162","volume":"15","author":"RL Jones","year":"2000","unstructured":"Jones RL, Critchley HO (2000) Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 15(Suppl. 3):162\u2013172","journal-title":"Hum Reprod"},{"key":"4261_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004347-198609000-00005","volume":"5","author":"SG Silverberg","year":"1986","unstructured":"Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T (1986) Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 5:235\u2013241","journal-title":"Int J Gynecol Pathol"},{"key":"4261_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0010-7824(87)90060-6","volume":"36","author":"ME Ortiz","year":"1987","unstructured":"Ortiz ME, Croxatto HB (1987) The mode of action of IUDs. Contraception 36:37\u201353","journal-title":"Contraception"},{"key":"4261_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.contraception.2012.01.015","volume":"86","author":"B Seeber","year":"2012","unstructured":"Seeber B, Ziehr SC, Gschlie\u03b2er A, Moser C, Mattle V, Seger C, Griesmacher A, Concin N, Concin H, Wildt L (2012) Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system. Contraception 86:345\u2013349","journal-title":"Contraception"},{"key":"4261_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(90)90092-A","volume":"42","author":"I Barbosa","year":"1990","unstructured":"Barbosa I, Olsson SE, Odlind V, Goncalves T, Coutinho E (1990) Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 42:51\u201366","journal-title":"Contraception"},{"key":"4261_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0010-7824(89)90050-4","volume":"40","author":"PD Zhu","year":"1989","unstructured":"Zhu PD, Luo HZ, Xu RH, Cheng J, Wu SC, Chen JH, Wu MZ, Wang XP (1989) The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium\u2014a comparative study of three IUDs. Contraception 40:425\u2013438","journal-title":"Contraception"},{"key":"4261_CR9","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1210\/jc.2005-2748","volume":"91","author":"M Hickey","year":"2006","unstructured":"Hickey M, Crewe J, Mahoney LA, Doherty DA, Fraser IS, Salamonsen LA (2006) Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. J Clin Endocrinol Metab 91:3189\u20133198","journal-title":"J Clin Endocrinol Metab"},{"key":"4261_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07853899009147248","volume":"22","author":"T Luukkainen","year":"1990","unstructured":"Luukkainen T, L\u00e4hteenm\u00e4ki P, Toivonen J (1990) Levonorgestrel releasing intrauterine device. Ann Med 22:85\u201390","journal-title":"Ann Med"},{"key":"4261_CR11","first-page":"131","volume":"14","author":"GE Robinson","year":"1989","unstructured":"Robinson GE, Bounds W, Kubba AA, Adams J, Guillebaud J (1989) Functional ovarian cysts associated with the levonorgestrel releasing intrauterine device. Br J Fam Plann 14:131\u2013132","journal-title":"Br J Fam Plann"},{"key":"4261_CR12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00006250-200606000-00058","volume":"107","author":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice","year":"2006","unstructured":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice (2006) ACOG Committee Opinion. No337: Noncontraceptive uses of the levonorgestrel intrauterine system. Obstet Gynecol 107:1479\u20131482","journal-title":"Obstet Gynecol"},{"key":"4261_CR13","unstructured":"World Health Organization (WHO) (2010) Medical Eligibility Criteria for Contraceptive Use-4th ed 2009. WHO, Geneva"},{"issue":"RR-4","key":"4261_CR14","first-page":"1","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention (2010) US Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep 59(RR-4):1\u201386","journal-title":"MMWR Recomm Rep"},{"key":"4261_CR15","unstructured":"Faculty of Sexual and Reproductive Health Care (2009) The Royal College of Obstetricians and Gynecologists. UK Medical Eligibility Criteria for Contraceptive Use. Faculty of Sexual and Reproductive Health Care, London"},{"key":"4261_CR16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e3182723b7d","volume":"120","author":"Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists","year":"2012","unstructured":"Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists (2012) Committee Opinion No539: adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol 120:983\u2013988","journal-title":"Obstet Gynecol"},{"key":"4261_CR17","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1542\/peds.2014-2299","volume":"134","author":"Committee on Adolescence, The American Pediatric Academy","year":"2014","unstructured":"Committee on Adolescence, The American Pediatric Academy (2014) Contraception for Adolescents. Pediatrics 134:1244\u20131256","journal-title":"Pediatrics"},{"key":"4261_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2010.01.010","volume":"81","author":"R Lyus","year":"2010","unstructured":"Lyus R, Lohr P, Prager S, Board of the Society of Family Planning (2010) Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception 81:367\u2013371","journal-title":"Contraception"},{"key":"4261_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1701-2163(15)30636-8","volume":"36","author":"S Caddy","year":"2014","unstructured":"Caddy S, Yudin MH, Hakim J, Money DM, Infectious Disease Committee; Society of Obstetricians and Gynaecologists of Canada (2014) Best practices to minimize risk of infection with intrauterine device insertion. J Obstet Gynaecol Can 36:266\u2013276","journal-title":"J Obstet Gynaecol Can"},{"key":"4261_CR20","volume-title":"Contraceptive Choices for Young People","author":"Faculty of Sexual and Reproductive Health Care Clinical Guidance. The Royal College of Obstetricians and Gynecologists","year":"2010","unstructured":"Faculty of Sexual and Reproductive Health Care Clinical Guidance. The Royal College of Obstetricians and Gynecologists (2010) Contraceptive Choices for Young People. Faculty of Sexual and Reproductive Health Care, London"},{"key":"4261_CR21","unstructured":"ANAES, INPES, AFSSAPS (2004). Strat\u00e9gies de choix des m\u00e9thodes contraceptives chez la femme. Available at: http:\/\/www.inpes.sante.fr\/70000\/dp\/04\/dp041207.pdf . Accessed April 4, 2015"},{"key":"4261_CR22","unstructured":"Sexual Health and Family Planning Australia (SH&FPA) (2013). Time for a Change: Increasing the Use of Long-Acting Reversible Contraceptive methods in Australia. SH&FPA"},{"key":"4261_CR23","volume-title":"Adolescent friendly health services\u2014an agenda for change","author":"World Health Organization","year":"2002","unstructured":"World Health Organization (2002) Adolescent friendly health services\u2014an agenda for change. WHO, Geneva"},{"key":"4261_CR24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/AOG.0b013e31828b63a0","volume":"121","author":"AB Berenson","year":"2013","unstructured":"Berenson AB, Tan A, Hirth JM, Wilkinson GS (2013) Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet Gynecol 121:951\u2013958","journal-title":"Obstet Gynecol"},{"key":"4261_CR25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/AOG.0b013e31827499bd","volume":"120","author":"JR Rosenstock","year":"2012","unstructured":"Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM (2012) Continuation of reversible contraception in teenagers and young women. Obstet Gynecol 120:1298\u20131305","journal-title":"Obstet Gynecol"},{"key":"4261_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpag.2014.01.102","volume":"27","author":"AM Amies Oelschlager","year":"2014","unstructured":"Amies Oelschlager AM, Micks EA, Debiec KE, Nizamic T, Mantrala MD, Prager SW (2014) Long acting reversible contraception in adolescents with cardiovascular conditions. J Pediatr Adolesc Gynecol 27:353\u2013355","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/jwh.2010.2462","volume":"20","author":"JB Hillman","year":"2011","unstructured":"Hillman JB, Miller RJ, Inge TH (2011) Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients. J Womens Health (Larchmt) 20:533\u2013538","journal-title":"J Womens Health (Larchmt)"},{"key":"4261_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.contraception.2009.09.004","volume":"81","author":"EM Godfrey","year":"2010","unstructured":"Godfrey EM, Memmel LM, Neustadt A, Shah M, Nicosia A, Moorthie M, Gilliam M (2010) Intrauterine contraception for adolescents aged 14\u201318\u00a0years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T380A. Contraception 81:123\u2013127","journal-title":"Contraception"},{"key":"4261_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0000000000000144","volume":"123","author":"J Aoun","year":"2014","unstructured":"Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V (2014) Effects of age, parity and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol 123:585\u2013592","journal-title":"Obstet Gynecol"},{"key":"4261_CR30","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.contraception.2011.05.010","volume":"84","author":"T Behringer","year":"2011","unstructured":"Behringer T, Reevers MF, Rossiter B, Chen BA, Schwarz EB (2011) Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women. Contraception 84:e5\u2013e10","journal-title":"Contraception"},{"key":"4261_CR31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.contraception.2011.07.001","volume":"85","author":"SB Teal","year":"2012","unstructured":"Teal SB, Sheeder J (2012) IUD use in adolescent mothers: retention, failure and reasons for discontinuation. Contraception 85:270\u2013274","journal-title":"Contraception"},{"key":"4261_CR32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpag.2013.07.013","volume":"26","author":"DL Howard","year":"2013","unstructured":"Howard DL, Wayman R, Strickland JL (2013) Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12\u00a0months of follow-up. J Pediatr Adolesc Gynecol 26:358\u2013365","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.contraception.2008.12.001","volume":"79","author":"H Paterson","year":"2009","unstructured":"Paterson H, Ashton J, Harrison-Woolrych M (2009) A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception 79:433\u2013438","journal-title":"Contraception"},{"key":"4261_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpag.2009.11.008","volume":"23","author":"C Chi","year":"2010","unstructured":"Chi C, Pollard D, Tuddenham EG, Kadir RA (2010) Menorrhagia in adolescents with inherited bleeding disorders. J Pediatr Adolesc Gynecol 23:215\u2013222","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-008833","author":"CD Silva","year":"2013","unstructured":"Silva CD, Geraldes F, Silva IS (2013) Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type III von Willebrand disease. BMJ Case Rep.\u00a0doi: 10.1136\/bcr-2013-008833","journal-title":"BMJ Case Rep"},{"key":"4261_CR36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpag.2012.11.002","volume":"26","author":"J Yoost","year":"2013","unstructured":"Yoost J, LaJoie AS, Hertweck P, Loveless M (2013) Use of the levonorgestrel intrauterine system in adolescents with endometriosis. J Pediatr Adolesc Gynecol 26:120\u2013124","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1479-828X.2007.00727.x","volume":"47","author":"M Al-Jefout","year":"2007","unstructured":"Al-Jefout M, Palmer J, Fraser IS (2007) Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating endometriosis. Aust N Z J Obstet Gynaecol 47:247\u2013249","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"4261_CR38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/01443610903452773","volume":"30","author":"M Williamson","year":"2010","unstructured":"Williamson M, Bulmer P (2010) Using the Mirena intrauterine system to treat severe primary dysmenorrhoea in an adolescent. J Obstet Gynaecol 30:206\u2013207","journal-title":"J Obstet Gynaecol"},{"key":"4261_CR39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/01443615.2010.484107","volume":"30","author":"N Aslam","year":"2010","unstructured":"Aslam N, Blunt S, Latthe P (2010) Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents. J Obstet Gynaecol 30:489\u2013491","journal-title":"J Obstet Gynaecol"},{"key":"4261_CR40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","volume":"117","author":"M Pillai","year":"2010","unstructured":"Pillai M, O\u2019Brien K, Hill E (2010) The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning diabilities. BJOG 117:216\u2013221","journal-title":"BJOG"},{"key":"4261_CR41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpag.2013.08.010","volume":"27","author":"I Savasi","year":"2014","unstructured":"Savasi I, Jayasinghe K, Moore P, Jayasinghe Y, Grover SR (2014) Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities. J Pediatr Adolesc Gynecol 27:25\u201328","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpag.2012.05.005","volume":"25","author":"PJ Hillard","year":"2012","unstructured":"Hillard PJ (2012) Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay. J Pediatr Adolec Gynecol 25:308\u2013313","journal-title":"J Pediatr Adolec Gynecol"},{"key":"4261_CR43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jadohealth.2013.04.014","volume":"53","author":"YA Kirkham","year":"2013","unstructured":"Kirkham YA, Allen L, Kives S, Caccia N, Spitzer RF, Omstein MP (2013) Trends in menstrual concerns and suppression in adolescents with developmental disabilities. J Adolesc Health 53:407\u2013412","journal-title":"J Adolesc Health"},{"issue":"2 Pt 2","key":"4261_CR44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AOG.0b013e318234d97c","volume":"119","author":"AJ Brown","year":"2012","unstructured":"Brown AJ, Westin SN, Broaddus RR, Schmeler K (2012) Progestin intrauterine device in an adolescent with grade 2 endometrial cancer. Obstet Gynecol 119(2 Pt 2):423\u2013426","journal-title":"Obstet Gynecol"},{"key":"4261_CR45","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318273eb56","volume":"120","author":"JF Peipert","year":"2012","unstructured":"Peipert JF, Madden T, Allsworth JE, Secura GM (2012) Preventing unintended preg-nancies by providing no-cost contraception. Obstet Gynecol 120:1291\u20131297","journal-title":"Obstet Gynecol"},{"key":"4261_CR46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2011.03.001","volume":"84","author":"R Mestad","year":"2011","unstructured":"Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF (2011) Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception 84:493\u2013498","journal-title":"Contraception"},{"key":"4261_CR47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpag.2014.02.015","volume":"28","author":"JO Friedman","year":"2015","unstructured":"Friedman JO (2015) Factors associated with contraceptive satisfaction in adolescent women using the IUD. J Pediatr Adolesc Gynecol 28:38\u201342","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000342822","volume":"78","author":"CE Williams","year":"2012","unstructured":"Williams CE, Creighton SM (2012) Menstrual disorders in adolescents: review of current practice. Horm Res Paediatr 78:135\u2013143","journal-title":"Horm Res Paediatr"},{"key":"4261_CR49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/humrep\/deg136","volume":"18","author":"MS Arruda","year":"2003","unstructured":"Arruda MS, Petta CA, Abrao MS, Benetti-Pinto CL (2003) Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod 18:4\u20139","journal-title":"Hum Reprod"},{"key":"4261_CR50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00006250-200504000-00058","volume":"105","author":"American College of Obstetricians and Gynecologists","year":"2005","unstructured":"American College of Obstetricians and Gynecologists (2005) ACOG Committee Opinion. Number 310, April 2005. Endometriosis in adolescents. Obstet Gynecol 105:921","journal-title":"Obstet Gynecol"},{"key":"4261_CR51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1083-3188(97)70085-8","volume":"10","author":"MR Laufer","year":"1997","unstructured":"Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ (1997) Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 10:199","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"4261_CR52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0145-2134(90)90002-B","volume":"14","author":"D Tharinger","year":"1990","unstructured":"Tharinger D, Horton CB, Millea S (1990) Sexual abuse and exploitation of children and adults with mental retardation and other handicaps. Child Abuse Negl 14:301","journal-title":"Child Abuse Negl"},{"key":"4261_CR53","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jadohealth.2006.03.011","volume":"39","author":"BA Cromer","year":"2006","unstructured":"Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM (2006) Depot medroxyprogesterone acetate and bone mineral density in adolescents\u2014the Black Box Warning: a Position Paper of the Society for Adolescent Medicine. J Adolesc Health 39:296\u2013301","journal-title":"J Adolesc Health"},{"key":"4261_CR54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-011-9180-6","volume":"12","author":"MM Isley","year":"2011","unstructured":"Isley MM, Kaunitz AM (2011) Update on hormonal contraception and bone density. Rev Endocr Metab Disord 12:93","journal-title":"Rev Endocr Metab Disord"},{"key":"4261_CR55","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/AOG.0b013e3181c6f922","volume":"114","author":"American College of Obstetricians and Gynecologists Committee on Adolescent Health Care","year":"2009","unstructured":"American College of Obstetricians and Gynecologists Committee on Adolescent Health Care (2009) ACOG Committee Opinion no. 448: Menstrual manipulation for adolescents with disabilities. Obstet Gynecol 114:1428","journal-title":"Obstet Gynecol"},{"key":"4261_CR56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.0004-8666.2003.00046.x","volume":"43","author":"E Atkinson","year":"2003","unstructured":"Atkinson E, Bennett MJ, Dudley J, Grover S, Matthews K, Moore P, Quinlivan J, Walters T, Australian Society of Paediatric and Adolescent Gynaecology Working Party (2003) Consensus statement: Menstrual and contraceptive management in women with an intellectual disability. Aust N Z J Obstet Gynaecol 43:109","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"4261_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ultrasmedbio.2003.09.009","volume":"30","author":"A Gadelha Da Costa","year":"2004","unstructured":"Gadelha Da Costa A, Filho FM, Ferreira AC, Spara P, Mauad FM (2004) Uterine volume in adolescents. Ultrasound Med Biol 30:7\u201310","journal-title":"Ultrasound Med Biol"},{"key":"4261_CR58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1469-0705.1995.06030175.x","volume":"6","author":"K Holm","year":"1995","unstructured":"Holm K, Laursen EM, Brocks V, M\u00fcller J (1995) Pubertal maturation of internal genitalia: an ultrasound evaluation of 166 healthy girls. Ultrasound Obstet Gynecol 6:175\u2013181","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4261_CR59","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)38406-0","volume":"22","author":"I Kamal","year":"1971","unstructured":"Kamal I, Hefnawi F, Ghonheim M, Talant M, Abdalla M (1971) Dimensional and architectural disproportion between the intrauterine device and the uterine cavity: a cause of bleeding. Fert Steril 22:514\u2013521","journal-title":"Fert Steril"},{"key":"4261_CR60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.contraception.2012.03.014","volume":"86","author":"LL Bayer","year":"2012","unstructured":"Bayer LL, Jensen JT, Li H, Nichols MD, Bednarek PH (2012) Adolescent experience with intrauterine device insertion and use: a retrospective cohort study. Contraception 86:443\u2013451","journal-title":"Contraception"},{"key":"4261_CR61","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","volume":"339","author":"TM Farley","year":"1992","unstructured":"Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339:785\u2013788","journal-title":"Lancet"},{"key":"4261_CR62","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(97)09086-7","volume":"351","author":"T Walsh","year":"1998","unstructured":"Walsh T, Grimes D, Frezieres R, Nelson A, Bernstein L, Coulson A, Bernstein G (1998) Randomized controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet 351:1005\u20131008","journal-title":"Lancet"},{"key":"4261_CR63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AOG.0b013e318227f05e","volume":"118","author":"ACOG Practice Bulletin No. 121","year":"2011","unstructured":"ACOG Practice Bulletin No. 121 (2011) Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol 118:184\u2013196","journal-title":"Obstet Gynecol"},{"key":"4261_CR64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","volume":"77","author":"J Toivonen","year":"1991","unstructured":"Toivonen J, Luukkainen T, Allonen H (1991) Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years\u2019 comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol 77:261\u2013264","journal-title":"Obstet Gynecol"},{"key":"4261_CR65","doi-asserted-by":"crossref","unstructured":"Blanc AK, Tsui AO, Croft TN, Trevitt JL (2009) Patterns and trends in adolescents\u2019 contraceptive use and discontinuation in developing countries and comparisons with adult women. International perspectives on sexual and reproductive health. Int Perspect Sex Reprod Health, p 63\u201371","DOI":"10.1363\/3506309"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-016-4261-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:25:48Z","timestamp":1498353948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-016-4261-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,7]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["4261"],"URL":"https:\/\/doi.org\/10.1007\/s00404-016-4261-0","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,7]]}}}